IL6 and Schnyder corneal dystrophy: DMF also reduces inflammation and organ failure and improves the SCD phenotype [18,122], supported by decreased proinflammatory cytokines, such as interleukin-6 and interleukin-1β, and heme, and oxidative stress levels.